Nova Biomedical is the largest privately held in vitro diagnostics (IVD) company in the United States and the third largest in the world, employing over 1,500 people. Our eight percent compound annual growth rate over nearly a decade is nearly triple the average IVD market growth, making Nova one of the fastest growing IVD companies in the world.
Nova’s size and rapid growth are the result of customers throughout the world responding to the exceptional quality and value of Nova’s technology, products, and customer service. Our strong corporate commitment to these three areas has made Nova a world leader in critical care testing, point-of-care (POC) testing, and cell culture analysis for biochemistry.